Search research articles
Contact Us
Filters
Showing results (21-30 of 63) with videos related to
Page
of 7
Sort By:
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
March 15, 2021
Efficacy and Safety of Ertugliflozin in Patients with Type 2 Diabetes Inadequately Controlled by Metformin and Sulfonylurea: A Sub-Study of VERTIS CV
Matthew J Budoff, Timothy M E Davis, Alexandra G Palmer, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
January 15, 2015
A survey of patient preferences for oral antihyperglycemic therapy in patients with type 2 diabetes mellitus
A Brett Hauber, Kaan Tunceli, Jui-Chen Yang, et al.
Diabetes Care
|
August 28, 2015
Safety and Efficacy of Omarigliptin (MK-3102), a Novel Once-Weekly DPP-4 Inhibitor for the Treatment of Patients With Type 2 Diabetes
Wayne H-H Sheu, Ira Gantz, Menghui Chen, et al.
Current Medical Research and Opinion
|
April 24, 2020
Efficacy and safety of ertugliflozin across racial groups in patients with type 2 diabetes mellitus
Jie Liu, Lisa Tarasenko, Annpey Pong, et al.
Journal of Molecular Biology
|
February 11, 2005
Structures of the agouti signaling protein
Joseph C McNulty, Pilgrim J Jackson, Darren A Thompson, et al.
Biochemistry
|
June 12, 2002
Design, pharmacology, and NMR structure of a minimized cystine knot with agouti-related protein activity
Pilgrim J Jackson, Joseph C McNulty, Ying-Kui Yang, et al.
Current Medical Research and Opinion
|
May 27, 2017
A randomized clinical trial evaluating the efficacy and safety of the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapy
R Ravi Shankar, Silvio E Inzucchi, Victoria Scarabello, et al.
Diabetes, Obesity & Metabolism
|
December 5, 2019
Efficacy and safety of ertugliflozin in East/Southeast Asian patients with type 2 diabetes mellitus
Jie Liu, Shrita Patel, Nilo B Cater, et al.
Current Medical Research and Opinion
|
April 24, 2020
Efficacy and safety of ertugliflozin in Hispanic/Latino patients with type 2 diabetes mellitus
Jie Liu, Lisa Tarasenko, Annpey Pong, et al.
The AAPS Journal
|
June 29, 2010
Development of a population pharmacokinetic model for taranabant, a cannibinoid-1 receptor inverse agonist
Xiujiang Susie Li, Jace Nielsen, Brenda Cirincione, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 63) with videos related to
Sort By:
Page
of 7
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
March 15, 2021
Efficacy and Safety of Ertugliflozin in Patients with Type 2 Diabetes Inadequately Controlled by Metformin and Sulfonylurea: A Sub-Study of VERTIS CV
Matthew J Budoff, Timothy M E Davis, Alexandra G Palmer, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
January 15, 2015
A survey of patient preferences for oral antihyperglycemic therapy in patients with type 2 diabetes mellitus
A Brett Hauber, Kaan Tunceli, Jui-Chen Yang, et al.
Diabetes Care
|
August 28, 2015
Safety and Efficacy of Omarigliptin (MK-3102), a Novel Once-Weekly DPP-4 Inhibitor for the Treatment of Patients With Type 2 Diabetes
Wayne H-H Sheu, Ira Gantz, Menghui Chen, et al.
Current Medical Research and Opinion
|
April 24, 2020
Efficacy and safety of ertugliflozin across racial groups in patients with type 2 diabetes mellitus
Jie Liu, Lisa Tarasenko, Annpey Pong, et al.
Journal of Molecular Biology
|
February 11, 2005
Structures of the agouti signaling protein
Joseph C McNulty, Pilgrim J Jackson, Darren A Thompson, et al.
Biochemistry
|
June 12, 2002
Design, pharmacology, and NMR structure of a minimized cystine knot with agouti-related protein activity
Pilgrim J Jackson, Joseph C McNulty, Ying-Kui Yang, et al.
Current Medical Research and Opinion
|
May 27, 2017
A randomized clinical trial evaluating the efficacy and safety of the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapy
R Ravi Shankar, Silvio E Inzucchi, Victoria Scarabello, et al.
Diabetes, Obesity & Metabolism
|
December 5, 2019
Efficacy and safety of ertugliflozin in East/Southeast Asian patients with type 2 diabetes mellitus
Jie Liu, Shrita Patel, Nilo B Cater, et al.
Current Medical Research and Opinion
|
April 24, 2020
Efficacy and safety of ertugliflozin in Hispanic/Latino patients with type 2 diabetes mellitus
Jie Liu, Lisa Tarasenko, Annpey Pong, et al.
The AAPS Journal
|
June 29, 2010
Development of a population pharmacokinetic model for taranabant, a cannibinoid-1 receptor inverse agonist
Xiujiang Susie Li, Jace Nielsen, Brenda Cirincione, et al.
Page
of 7